Why It Matters
Sidecar Health is lobbying to advance regulatory and tax policies that support its core business model: empowering consumers with price transparency to shop for healthcare services. Consumers still lack actionable pricing information despite years of transparency mandates. Legislative solutions would include standardizing price transparency requirements and expanding tax incentives for consumer-directed health plans and Health Savings Accounts.
Sidecar’s strategy deploys a multi-firm lobbying approach with deep bipartisan congressional connections, particularly Smith-Free Group LLC, to capitalize on strong bipartisan momentum around healthcare affordability.
By the Numbers
Sidecar Health Inc. paid Smith-Free Group LLC $50,000 in the last quarter of 2025, continuing a relationship that has generated $650,000 total. The company has spent $7.087 million on lobbying since 2019 across multiple firms.
Sidecar’s lobbying relies on a sophisticated multi-firm approach. In-house lobbying accounts for $4.485 million since 2021. External firms include Todd Strategy Group ($900,000 since 2021), Nickles Group LLC ($660,000 through 2022), and Brownstein Hyatt Farber Schreck LLP ($530,000 since 2023).
Three experienced lobbyists from Smith-Free Group are deployed. Michael A. Gaffin brings 9.5 years in Congress including service as Legislation Director for the bipartisan Northeast-Midwest Senate Coalition. John Christie III served as Chief of Staff to Rep. Alma Adams (D-NC), and Michael P. Mullen has six years of congressional service.
The Agenda
Sidecar Health is lobbying on healthcare transparency and taxation of medical expenses, including engagement on P.L. 119-21, the "One Big Beautiful Bill Act." The company’s advocacy has consistently focused on consumer-directed healthcare, price transparency, surprise medical billing, and tax treatment of medical expenses. Previous efforts included support for H.R. 5378, the "Lower Costs, More Transparency Act," which directly aligns with Sidecar’s business model of empowering consumers with pricing information.
Broader Context
Sidecar’s fourth quarter 2025 lobbying occurs amid significant Congressional focus on healthcare affordability. Health insurance premiums spiked dramatically, with benchmark ACA plans rising 26% on average in 2026 and Medicare Part B premiums jumping nearly 10%.
Price transparency has emerged as a central Congressional priority. The bipartisan Patients Deserve Price Tags Act would codify and expand federal price transparency rules, while the Trump administration issued an executive order directing agencies to rapidly implement healthcare price transparency regulations.
Consumer-directed health plans are gaining mainstream adoption. Enrollment in high-deductible health plans reaches 19.5 percent of privately insured people under 65, and Health Savings Account assets hit $137 billion in 2024.
Between The Lines
Congress is actively legislating on Sidecar’s priorities. The Patients Deserve Price Tags Act has strong bipartisan support with 18 cosponsors. Senator Tammy Baldwin (D-WI) has championed the bill for creating "true transparency." Republicans are advancing complementary proposals: Senator Rick Scott (R-FL) introduced the "More Affordable Care Act" promoting Health Freedom Accounts, while Senator Rand Paul (R-KY) seeks to expand HSAs.
Additional transparency bills—including the Health Care PRICE Transparency Act and PBM Reform Act of 2025—demonstrate broad congressional momentum on pricing disclosure.
Competitive Landscape
The Self-Insurance Institute of America Inc. is actively lobbying on surprise billing protections and price transparency. The California Schools Voluntary Employee Benefits Association advocates for the Lower Costs, More Transparency Act, strengthening a broader coalition aligned with Sidecar’s objectives.
The Bottom Line
Sidecar Health’s last quarter of 2025 engagement represents continuation of its multi-year lobbying strategy, deploying experienced lobbyists with bipartisan congressional backgrounds. With strong bipartisan momentum behind transparency bills like the Patients Deserve Price Tags Act and Republican support for consumer-directed health models, the policy environment appears favorable for Sidecar’s advocacy objectives.
Access the Legis1 platform for comprehensive political news, data, and insights.